Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. NEJM. July 17th, 2020

Spread the word

Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. For more information, please click here.

Leave a Reply

Your email address will not be published. Required fields are marked *